Form D · Other Health Care
Synapticure, Inc.
Chicago, IL · CIK 0002038193
Offering snapshot reported Sep 24, 2024 · SEC filing
- Reported sold
- $40.1M Offering amount: $40.1M
- Investors reported
- 51 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 9, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2024 | Initial | $40,145,500 | No comparison | 51 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524793
Includes shares of preferred stock issued pursuant to the cancellation of SAFE indebtedness in the amount of $16,645,500.
Source: Form D, filed Sep 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sandra Abrevaya | Director, Executive |
| Eric Anderson | Executive |
| Jason Langheier | Director |
| Joe Leinbach | Executive |
| Adam Seabrook | Director |
| Peter Wallach | Executive |
| Brian Wallach | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2045 W. Grand Ave Suite B
Chicago, IL, 60612
Chicago, IL, 60612